Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Five-year, Post-marketing Observational Study to Follow-up Patients With Rheumatoid Arthritis Formerly Treated in Study M02-497 (ReAct) and Subsequently Prescribed Humira

NCT00234884 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00234884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00234884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Five-year, Post-marketing Observational Study to Follow-up Patients With Rheumatoid Arthritis Formerly Treated in Study M02-497 (ReAct) and Subsequently Prescribed Humira
Lead sponsor
Abbott
Phase
Observational
Overall status
Completed
Start date
September 30, 2003
Completion date
July 31, 2010
Enrollment
3,435 (actual)
Sites
311

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis